692 related articles for article (PubMed ID: 26005850)
41. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
[TBL] [Abstract][Full Text] [Related]
42. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
[TBL] [Abstract][Full Text] [Related]
43. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
[TBL] [Abstract][Full Text] [Related]
44. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
[TBL] [Abstract][Full Text] [Related]
45. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
[TBL] [Abstract][Full Text] [Related]
46. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
[TBL] [Abstract][Full Text] [Related]
47. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
[TBL] [Abstract][Full Text] [Related]
48. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.
Deane R; Sagare A; Zlokovic BV
Curr Pharm Des; 2008; 14(16):1601-5. PubMed ID: 18673201
[TBL] [Abstract][Full Text] [Related]
49. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain.
Sagare AP; Bell RD; Srivastava A; Sengillo JD; Singh I; Nishida Y; Chow N; Zlokovic BV
J Biol Chem; 2013 May; 288(21):15154-66. PubMed ID: 23580652
[TBL] [Abstract][Full Text] [Related]
50. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
51. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice.
Gali CC; Fanaee-Danesh E; Zandl-Lang M; Albrecher NM; Tam-Amersdorfer C; Stracke A; Sachdev V; Reichmann F; Sun Y; Avdili A; Reiter M; Kratky D; Holzer P; Lass A; Kandimalla KK; Panzenboeck U
Mol Cell Neurosci; 2019 Sep; 99():103390. PubMed ID: 31276749
[TBL] [Abstract][Full Text] [Related]
52. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
53. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
Thomas RS; Alsaqati M; Bice JS; Hvoslef-Eide M; Good MA; Kidd EJ
Neuroreport; 2017 Oct; 28(15):963-968. PubMed ID: 28885485
[TBL] [Abstract][Full Text] [Related]
54. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
55. Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models.
Israel LL; Galstyan A; Cox A; Shatalova ES; Sun T; Rashid MH; Grodzinski Z; Chiechi A; Fuchs DT; Patil R; Koronyo-Hamaoui M; Black KL; Ljubimova JY; Holler E
ACS Nano; 2022 Aug; 16(8):11815-11832. PubMed ID: 35961653
[TBL] [Abstract][Full Text] [Related]
56. In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
Candela P; Saint-Pol J; Kuntz M; Boucau MC; Lamartiniere Y; Gosselet F; Fenart L
Brain Res; 2015 Jan; 1594():15-26. PubMed ID: 25451130
[TBL] [Abstract][Full Text] [Related]
57. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
58. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
59. Genetics of PICALM expression and Alzheimer's disease.
Parikh I; Fardo DW; Estus S
PLoS One; 2014; 9(3):e91242. PubMed ID: 24618820
[TBL] [Abstract][Full Text] [Related]
60. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
